X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56) 56
humans (46) 46
oncology (43) 43
male (22) 22
cancer (21) 21
female (20) 20
middle aged (18) 18
aged (17) 17
article (17) 17
adult (15) 15
stomach neoplasms - pathology (15) 15
tumors (15) 15
chemotherapy (13) 13
gastric cancer (13) 13
gene amplification (13) 13
adenocarcinoma (11) 11
c-met (11) 11
survival (11) 11
treatment outcome (11) 11
aged, 80 and over (10) 10
clinical trials (10) 10
mutation (10) 10
stomach cancer (10) 10
stomach neoplasms - genetics (10) 10
cancer therapies (9) 9
expression (9) 9
open-label (9) 9
advanced gastric-cancer (8) 8
biomarkers (8) 8
double-blind (8) 8
esophageal neoplasms - pathology (8) 8
gastric-cancer (8) 8
metastasis (8) 8
prognosis (8) 8
stomach neoplasms - drug therapy (8) 8
adenocarcinoma - drug therapy (7) 7
amplification (7) 7
breast-cancer (7) 7
care and treatment (7) 7
esophageal cancer (7) 7
esophageal neoplasms - genetics (7) 7
met (7) 7
molecular targeted therapy (7) 7
neoplasm staging (7) 7
pancreatic cancer (7) 7
patients (7) 7
adenocarcinoma - pathology (6) 6
antineoplastic agents - therapeutic use (6) 6
biomarkers, tumor - genetics (6) 6
disease-free survival (6) 6
growth (6) 6
hematology, oncology and palliative medicine (6) 6
her2 (6) 6
medical prognosis (6) 6
precision medicine (6) 6
research (6) 6
surgery (6) 6
therapy (6) 6
abridged index medicus (5) 5
adenocarcinoma - genetics (5) 5
adenocarcinoma - metabolism (5) 5
adenocarcinoma - mortality (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
biomarkers, tumor - metabolism (5) 5
cell line, tumor (5) 5
cell lung-cancer (5) 5
cisplatin (5) 5
clinical trials as topic (5) 5
egfr (5) 5
esophagogastric junction - pathology (5) 5
fluorouracil - administration & dosage (5) 5
gastroesophageal adenocarcinoma (5) 5
growth-factor receptor (5) 5
neoplasms - genetics (5) 5
proteins (5) 5
stomach neoplasms - metabolism (5) 5
stomach neoplasms - mortality (5) 5
animals (4) 4
capecitabine (4) 4
esophageal neoplasms - drug therapy (4) 4
esophageal neoplasms - mortality (4) 4
fluorouracil (4) 4
gastroenterology & hepatology (4) 4
gastrointestinal cancer (4) 4
gene expression (4) 4
growth factors (4) 4
hematology (4) 4
heterogeneity (4) 4
immunohistochemistry (4) 4
kaplan-meier estimate (4) 4
kinases (4) 4
leucovorin - administration & dosage (4) 4
medicine (4) 4
medicine, research & experimental (4) 4
molecular targeted therapy - methods (4) 4
multicenter (4) 4
neoplasm metastasis (4) 4
neoplasms (4) 4
organoplatinum compounds - administration & dosage (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer discovery, ISSN 2159-8274, 02/2019, Volume 9, Issue 2, pp. 166 - 168
Sanchez-Vega and colleagues prospectively demonstrate that both intra-and intertumoral differential expression of the receptor tyrosine kinases HER2, EGFR, and... 
HETEROGENEITY | RESISTANCE | THERAPY | ONCOLOGY
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 08/2019, Volume 37, Issue 24, pp. 2177 - 2177
Journal Article
Biometrics, ISSN 0006-341X, 06/2017, Volume 73, Issue 2, pp. 367 - 377
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e54014
Purpose: The receptors for hepatocyte and vascular endothelial cell growth factors (MET and VEGFR2, respectively) are critical oncogenic mediators in gastric... 
ACTIVATION | AMPLIFICATION | GENE | MULTIDISCIPLINARY SCIENCES | C-MET | ACQUIRED-RESISTANCE | SUNITINIB | PROGNOSTIC MARKER | CARCINOMA | EXPRESSION | VASCULAR ENDOTHELIAL GROWTH | Anilides - therapeutic use | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Treatment Outcome | Antineoplastic Agents - therapeutic use | Stomach Neoplasms - drug therapy | Quinolines - pharmacology | Xenograft Model Antitumor Assays | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Neoplasm Metastasis | Animals | Anilides - pharmacology | Aged, 80 and over | Adult | Female | Aged | Antineoplastic Agents - pharmacology | Mice | Quinolines - therapeutic use | Hypertension | Cancer patients | Aspartate | Metastasis | Drug therapy | Stomach cancer | Cancer | Endothelium | Adenocarcinoma | Schedules | Carcinoma | Oncology | Kinases | Axl protein | Metastases | c-Met protein | Liver cancer | Receptors | Cell growth | Tumorigenesis | MET protein | Safety | Vascular endothelial growth factor | Growth factors | Gastric cancer | Medical research | Dosing | Receiving | Pharmacology | Patients | Endothelial cells | Ron protein | Amplification | Signaling | Gene amplification | Inhibitors | Correlation analysis | Medical prognosis | Biomarkers | Aspartate aminotransferase | Mutation | Pharmacokinetics | Tumors
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2015, Volume 112, Issue 47, pp. E6496 - E6505
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 36, pp. 4284 - 4292
Journal Article
Journal Article